96 related articles for article (PubMed ID: 20127815)
1. The comparison of mouse full metallothionein-1 versus alpha and beta domains and metallothionein-1-to-3 mutation following traumatic brain injury reveals different biological motifs.
Manso Y; Serra M; Comes G; Giralt M; Carrasco J; Cols N; Vasák M; González-Duarte P; Hidalgo J
J Neurosci Res; 2010 Jun; 88(8):1708-18. PubMed ID: 20127815
[TBL] [Abstract][Full Text] [Related]
2. Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.
Penkowa M; Tio L; Giralt M; Quintana A; Molinero A; Atrian S; Vasák M; Hidalgo J
J Neurosci Res; 2006 May; 83(6):974-84. PubMed ID: 16493670
[TBL] [Abstract][Full Text] [Related]
3. Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior.
Quintana A; Molinero A; Florit S; Manso Y; Comes G; Carrasco J; Giralt M; Borup R; Nielsen FC; Campbell IL; Penkowa M; Hidalgo J
J Neurosci Res; 2007 Sep; 85(12):2668-85. PubMed ID: 17131423
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
[TBL] [Abstract][Full Text] [Related]
7. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.
Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J
Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443
[TBL] [Abstract][Full Text] [Related]
8. Metallothioneins I and II: neuroprotective significance during CNS pathology.
Stankovic RK; Chung RS; Penkowa M
Int J Biochem Cell Biol; 2007; 39(3):484-9. PubMed ID: 17097331
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein-1+2 protect the CNS after a focal brain injury.
Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6.
Giralt M; Penkowa M; Hernández J; Molinero A; Carrasco J; Lago N; Camats J; Campbell IL; Hidalgo J
Neurobiol Dis; 2002 Apr; 9(3):319-38. PubMed ID: 11950277
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein I and II mitigate age-dependent secondary brain injury.
Natale JE; Knight JB; Cheng Y; Rome JE; Gallo V
J Neurosci Res; 2004 Nov; 78(3):303-14. PubMed ID: 15389833
[TBL] [Abstract][Full Text] [Related]
14. Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice.
Penkowa M; Cáceres M; Borup R; Nielsen FC; Poulsen CB; Quintana A; Molinero A; Carrasco J; Florit S; Giralt M; Hidalgo J
J Neurosci Res; 2006 Nov; 84(7):1452-74. PubMed ID: 16941634
[TBL] [Abstract][Full Text] [Related]
15. Analysis of metallothionein brain gene expression in relation to ethanol preference in mice using cosegregation and gene knockouts.
Loney KD; Uddin RK; Singh SM
Alcohol Clin Exp Res; 2006 Jan; 30(1):15-25. PubMed ID: 16433728
[TBL] [Abstract][Full Text] [Related]
16. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice.
Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of cathepsin D, metallothioneins-1 and -2, osteopontin, and tenascin-C in a mouse spinal cord injury model by cDNA microarray analysis.
Hashimoto M; Koda M; Ino H; Yoshinaga K; Murata A; Yamazaki M; Kojima K; Chiba K; Mori C; Moriya H
Acta Neuropathol; 2005 Feb; 109(2):165-80. PubMed ID: 15592854
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the metallothionein gene in liver and brain of mice and rats.
Choudhuri S; McKim JM; Klaassen CD
Toxicol Appl Pharmacol; 1993 Mar; 119(1):1-10. PubMed ID: 8470112
[TBL] [Abstract][Full Text] [Related]
19. Regulation of metallothionein genes in the American oyster (Crassostrea virginica): ontogeny and differential expression in response to different stressors.
Jenny MJ; Warr GW; Ringwood AH; Baltzegar DA; Chapman RW
Gene; 2006 Sep; 379():156-65. PubMed ID: 16846698
[TBL] [Abstract][Full Text] [Related]
20. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.
Penkowa M; Moos T; Carrasco J; Hadberg H; Molinero A; Bluethmann H; Hidalgo J
Glia; 1999 Feb; 25(4):343-57. PubMed ID: 10028917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
